Promote Innovation LLC v. Ranbaxy Laboratories Inc, No. 2:10-cv-00121 (E.D. Tex. Aug. 9, 2010)
From the Opinion
The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.
The above-titled and numbered civil action was referred to United States Magistrate Judge Chad Everingham pursuant to 28 U.S.C. § 636. The report of the Magistrate Judge (Dkt. No. 16), which contains his recommendation that the court deny the defendant Ranbaxy Laboratories, Inc.’s (“Ranbaxy”) motion to dismiss (Dkt. No. 8), and instead grant leave for the plaintiff Promote Innovation LLC (“Promote”) to amend its complaint, has been presented for consideration. On August 2, 2010, Promote objected to Judge Everingham’s report and recommendation (Dkt. No.
Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error